Tag: IpsiHand
Newly published BCI study confirms IpsiHand’s ability to improve post-stroke motor...
Kandu has announced the publication in Stroke: Vascular and Interventional Neurology of BCI-REHAB—a US National Institutes of Health (NIH)-sponsored randomised controlled trial of the company's...
BCI-enabled stroke rehabilitation therapy significantly improves functional outcomes in randomised trial
Kandu has announced results from what it describes as the first randomised controlled trial (RCT) evaluating a US Food and Drug Administration (FDA)-cleared, non-invasive...
Kandu Health and Neurolutions merge to form “new leader” in stroke...
Kandu Health and Neurolutions announced yesterday that they have merged to form Kandu Inc—a company that “expects to set a new standard of care...
Neurolutions and Kandu partner to accelerate access to improved stroke rehabilitation
Neurolutions and Kandu Health recently announced a strategic partnership intended to raise the standard of care for post-stroke recovery. Through this partnership, Kandu’s expert...
